Ibotta, Inc.
NYSE:IBTASoftware - Application
-$0.19 today
- Market cap
- $1.16B
- Beta
- -0.58
- P/E (TTM)
- -96.1
- EPS (TTM)
- -$0.30
Volume 0.45M
Average 0.22M
IBTA Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Ibotta, Inc.NYSE: IBTA
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables falls 16.6% from a year ago
Net receivables stood at $183.05M at the end of Q1 FY2026, down 16.6% from a year earlier and down 12.3% from the prior quarter. Over 3 fiscal years it compounded at +19.7% a year.
Context
- Net receivables amounted to 38.1% of total assets at the end of Q1 FY2026, up 3.8 pp from a year earlier.
- Net receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -16.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 208.71M USD
- Year-over-year change
- -5.5%
- 3-year CAGR
- +19.7%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 208.71M | -5.5% |
| FY2024 | 2024-12-31 | 220.88M | -2.5% |
| FY2023 | 2023-12-31 | 226.44M | +86.3% |
| FY2022 | 2022-12-31 | 121.56M | — |
Net Receivables vs competitors
How IBTA compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -16.6% is the 8th highest of 10, against a peer median of +6.1%.
- Net receivables amounts to 38.1% of total assets for IBTA, versus a peer median of 13.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | CN¥3.72B CNY | -24.2% | +2.5% | 8.2% | |
| Mar 2026 | $502.56M USD | +9.3% | +5.9% | 69.8% | |
| Mar 2026 | $251.24M USD | +32.2% | +12.1% | 29.9% | |
| Mar 2026 | $183.05M USD | -16.6% | +19.7% | 38.1% | |
| Mar 2026 | $58.83M USD | -5.5% | +13.6% | 17.3% | |
| Mar 2026 | $53.33M USD | +4.5% | +13.8% | 21.0% | |
| Mar 2026 | $34.07M USD | +6.1% | +8.9% | 9.1% | |
| Mar 2026 | $21.25M USD | +57.4% | -16.3% | 13.2% | |
| Mar 2026 | $11.91M USD | +23.5% | +24.6% | 10.6% | |
| Mar 2026 | $3.71M USD | -46.8% | +291.3% | 1.6% | |
| Peer median (excluding IBTA) | — | +6.1% | +12.1% | 13.2% | |
Competitors are the stored peer set for IBTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Cash & Equivalents | 17.82M | 62.59M | 349.28M | 186.61M |
| Short-term Investments | 27.68M | 0 | 0 | 0 |
| Net Receivables | 121.56M | 226.44M | 220.88M | 208.71M |
| Inventory | 0 | 0 | 0 | 0 |
| Other Current Assets | 7.4M | 922K | 1.24M | 12.6M |
| Total Current Assets | 174.46M | 298.34M | 581.74M | 407.93M |
| Property, Plant & Equipment (Net) | 5.56M | 3.37M | 1.95M | 33.34M |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 8.75M | 12.84M | 16.2M | 24.19M |
| Long-term Investments | 4.53M | 4.53M | 4.53M | 4.53M |
| Tax Assets | 1.52M | 0 | 0 | 54.85M |
| Other Non-current Assets | 263K | 699K | 74.01M | 1.08M |
| Total Non-current Assets | 20.62M | 21.45M | 96.69M | 117.99M |
| Total Assets | 195.08M | 319.79M | 678.43M | 525.91M |
| Account Payables | 5.86M | 8.94M | 7.16M | 10.84M |
| Short-term Debt | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 |
| Deferred Revenue | 3.05M | 2.63M | 4.96M | 2.94M |
| Other Current Liabilities | 117.63M | 107M | 94.46M | 78.58M |
| Total Current Liabilities | 143.9M | 198.15M | 204.17M | 207.76M |
| Long-term Debt | 61.05M | 64.45M | 0 | 25.5M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 24.93M | 29.26M | 16.98M | 5M |
| Total Non-current Liabilities | 85.98M | 93.71M | 16.98M | 30.5M |
| Total Liabilities | 229.87M | 291.86M | 221.15M | 238.26M |
| Common Stock | 0 | 0 | 0 | 0 |
| Retained Earnings | (247.31M) | (209.19M) | (140.45M) | (136.87M) |
| Accumulated OCI | (126K) | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Total Equity | (34.79M) | 27.93M | 457.28M | 287.65M |
| Total Debt | 61.05M | 64.45M | 0 | 25.5M |
| Net Debt | 43.23M | 1.86M | (349.28M) | (161.11M) |
Ibotta, Inc.
NYSE:IBTA
Intrinsic Alpha fair value
Locked
Current Price
$56.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.